Page 36 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon
P. 36

1522_C01.fm  Page 23  Tuesday, December 2, 2003  10:05 AM









                             1.4.1.2.8  Nonsteroidal Antiinflammatory Drugs (NSAIDs).  Nonopiod
                             analgesics are among the most commonly consumed over-the-counter prep-
                             arations all over the world. Besides acetylsalicylic acid, paracetamol, and
                             pyrazole derivatives, so-called NSAIDs, are used against acute and chronic
                             pain, inflammation, and fever.  Altough NSAIDs are perceived to be safe
                             drugs, they may lead to severe toxic effects in case of acute overdosage or in
                             case of chronic abuse. They are also misused in doping of humans and horses.
                             Therefore, they may be encountered in clinical and forensic toxicological
                             analysis, as well as in doping control. Analysis of such nonopioid analgesics
                             has been reviewed by Kraemer and Maurer. 212
                                NSAIDs are classified in arylacetic acid derivatives like indomethacin or
                             diclofenac; arylpropionic acid derivatives like ibuprofen, naproxen, or keto-
                             profen; or oxicames like piroxicam. All these drugs have acidic properties
                             due to (vinylogous) carboxyl groups. Many of the NSAIDs are chiral drugs
                             but most often marketed as racemates. It is known that the enantiomers have
                             different pharmacodynamic and pharmacokinetic properties. The anti-
                             inflammatory activity of NSAIDs has been shown to be mainly evoked by
                                             323
                             the S-enantiomers.  However, this stereoselectivity of action is not manifest
                             in vivo, due to the thus-far-unique unidirectional metabolic inversion of the
                             chiral center from the inactive R(–)-isomers to the active S(+)-antipodes. 324
                             Nevertheless, series of enantioselective determination procedures have been
                                                             325
                             published and reviewed by Davies   and Bhushan and Joshi.   Several
                                                                                      326
                             GC/MS, LC, CE, or TLC procedures have been published in the last years for
                             screening, confirmation, and/or quantification. Derivatization of NSAIDs
                             before GC is recommended to improve chromatographic properties and to
                             avoid thermal decarboxylation in the injection port of the GC. Most often,
                             ME after extraction is used, 55,214,265,269  but extractive methylation has also been
                             applied.  Silylation as an alternative for ME was studied for 26 NSAIDs. 267,268
                                    69
                                                             265
                             The procedures of Laakkonen et al.  and Gaillard  allowed simultaneous
                                                                          36
                             detection of other acidic drugs like barbiturates. Simultaneous determination
                             of 14 NSAIDs in plasma has been described using LC/MS. 327
                             1.4.2  General Screening Procedures for Simultaneous Detection
                                    of Several Drug Classes in Urine by GC/MS

                             In  so-called general unknown cases, comprehensive screening procedures
                             are needed which cover as many drugs or poisons as possible. Only a few
                             really comprehensive procedures have been published, mainly for urinalysis.
                             As already mentioned, analytical quality criteria of the parent compound
                             are of minor value if the concentrations of the metabolites are much higher
                             in urine than those of the parent drug and if the metabolites are detected
                             by the procedure. The procedure should be sufficiently sensitive to detect
                             therapeutic concentrations at least over a 12 to 24 h period after ingestion.

                             © 2004 by CRC Press LLC
   31   32   33   34   35   36   37   38   39   40   41